166 related articles for article (PubMed ID: 12525466)
1. Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes.
Palomba S; Numis FG; Mossetti G; Rendina D; Vuotto P; Russo T; Zullo F; Nappi C; Nunziata V
Hum Reprod; 2003 Jan; 18(1):192-8. PubMed ID: 12525466
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypes.
Palomba S; Numis FG; Mossetti G; Rendina D; Vuotto P; Russo T; Zullo F; Nappi C; Nunziata V
Clin Endocrinol (Oxf); 2003 Mar; 58(3):365-71. PubMed ID: 12608943
[TBL] [Abstract][Full Text] [Related]
3. BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.
Palomba S; Orio F; Russo T; Falbo A; Tolino A; Manguso F; Nunziata V; Mastrantonio P; Lombardi G; Zullo F
Osteoporos Int; 2005 Aug; 16(8):943-52. PubMed ID: 15739035
[TBL] [Abstract][Full Text] [Related]
4. The contribution of vitamin D receptor gene polymorphisms in osteoporosis and familial osteoporosis.
Fountas L; Moutsatsou P; Kastanias I; Tamouridis N; Tzanela M; Anapliotou M; Sekeris CE
Osteoporos Int; 1999; 10(5):392-8. PubMed ID: 10591837
[TBL] [Abstract][Full Text] [Related]
5. Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.
Meunier PJ; Vignot E; Garnero P; Confavreux E; Paris E; Liu-Leage S; Sarkar S; Liu T; Wong M; Draper MW
Osteoporos Int; 1999; 10(4):330-6. PubMed ID: 10692984
[TBL] [Abstract][Full Text] [Related]
6. [Association of bone mineral density with vitamin D receptor gene polymorphism--changes in radial bone mineral density with long-term follow-up: longitudinal study].
Murakami F; Hagino H; Shimomura T; Ikawa S; Hirano Y; Iijima K; Yamamoto K
Rinsho Byori; 1998 Aug; 46(8):766-73. PubMed ID: 9760828
[TBL] [Abstract][Full Text] [Related]
7. VDR genotype and response to etidronate therapy in late postmenopausal women.
Marc J; Prezelj J; Komel R; Kocijancic A
Osteoporos Int; 1999; 10(4):303-6. PubMed ID: 10692979
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor gene polymorphisms in a group of postmenopausal Turkish women: association wıth bone mineral density.
Yoldemir T; Yavuz DG; Anik G; Verimli N; Erenus M
Climacteric; 2011 Jun; 14(3):384-91. PubMed ID: 21413862
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Receptor Gene Polymorphisms Affect Osteoporosis-Related Traits and Response to Antiresorptive Therapy.
Mondockova V; Kovacova V; Zemanova N; Babikova M; Martiniakova M; Galbavy D; Omelka R
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672934
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor alleles, bone mineral density and turnover in postmenopausal osteoporotic and healthy women.
Duman BS; Tanakol R; Erensoy N; Oztürk M; Yilmazer S
Med Princ Pract; 2004; 13(5):260-6. PubMed ID: 15316258
[TBL] [Abstract][Full Text] [Related]
11. The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study.
Creatsa M; Pliatsika P; Kaparos G; Antoniou A; Armeni E; Tsakonas E; Panoulis C; Alexandrou A; Dimitraki E; Christodoulakos G; Lambrinoudaki I
J Obstet Gynaecol Res; 2011 Oct; 37(10):1415-22. PubMed ID: 21651652
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a meta-analysis from 26 studies.
Jia F; Sun RF; Li QH; Wang DX; Zhao F; Li JM; Pu Q; Zhang ZZ; Jin Y; Liu BL; Xiong Y
Genet Test Mol Biomarkers; 2013 Jan; 17(1):30-4. PubMed ID: 23134477
[TBL] [Abstract][Full Text] [Related]
13. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor gene polymorphism is associated with urinary calcium excretion but not with bone mineral density in postmenopausal women.
Ongphiphadhanakul B; Rajatanavin R; Chanprasertyothin S; Chailurkit L; Piaseu N; Teerarungsikul K; Sirisriro R; Komindr S; Puavilai G
J Endocrinol Invest; 1997 Nov; 20(10):592-6. PubMed ID: 9438916
[TBL] [Abstract][Full Text] [Related]
15. Relation of BsmI vitamin D receptor gene polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan.
Chen HY; Chen WC; Hsu CD; Tsai FJ; Tsai CH; Li CW
Osteoporos Int; 2001 Dec; 12(12):1036-41. PubMed ID: 11846330
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction.
Willing M; Sowers M; Aron D; Clark MK; Burns T; Bunten C; Crutchfield M; D'Agostino D; Jannausch M
J Bone Miner Res; 1998 Apr; 13(4):695-705. PubMed ID: 9556070
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women.
Hansen TS; Abrahamsen B; Henriksen FL; Hermann AP; Jensen LB; Hørder M; Gram J
Bone; 1998 May; 22(5):571-5. PubMed ID: 9600794
[TBL] [Abstract][Full Text] [Related]
18. Early and late postmenopausal bone loss is associated with BsmI vitamin D receptor gene polymorphism in Japanese women.
Kikuchi R; Uemura T; Gorai I; Ohno S; Minaguchi H
Calcif Tissue Int; 1999 Feb; 64(2):102-6. PubMed ID: 9914315
[TBL] [Abstract][Full Text] [Related]
19. [Effect of vitamin D receptor gene polymorphism on vitamin D therapy for postmenopausal bone loss].
Owada M; Suzuki K; Honda T; Yamada H; Tsukikawa S; Hoshi K; Sato A
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):799-805. PubMed ID: 8841046
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor genotype and bone mineral density in Caucasian children with congenital hypothyroidism.
Léger J; Tourrel C; Ruiz JC; Czernichow P; Garabedian M
J Pediatr Endocrinol Metab; 2000 Jun; 13(6):599-603. PubMed ID: 10905383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
